The FDA and NIH recently announced plans to phase out animal testing requirements for some therapies. While organoid and AI ...

The annual analysis documented approvals of 18 new personalized medicines in 2024, important regulatory milestones and establishment of the Center fo ...

Lalitha Amarapalli bridges science, software, and regulation to lead cutting-edge validation strategies that ensure data ...

The global electric acupuncture devices market is poised for steady growth over the next decade, with market size expected to increase from USD 15.9 million in 2025 to USD 32.8 million by 2035. Driven ...

BreachRx, provider of the first intelligent incident response platform designed for the entire enterprise, today announced the closing of an oversubscribed $15 million Series A funding round led by ...

Quantum computing is stepping out of the lab and into the real world, with practical applications already emerging across industries. This article demystifies the technology and shows why its ...

Clinical research company IQVIA (NYSE: IQV) reported Q1 CY2025 results , with sales up 2.5% year on year to $3.83 billion.

In today's interview, we speak to Aadel Chaudhuri (Vice Chair for Translational Research, Mayo Clinic) about the promise of liquid biopsy in cancer and beyond.

AI adoption in the corporate world is not a sprint—it’s a strategic journey where early experimentation gives way to ...

If the initiative proceeds as planned, it will mark a pivotal shift in the regulatory landscape, introducing both efficiencies and novel ...

Nvidia rolled into this year’s Computex Taipei tech expo on Monday with several announcements, ranging from the development ...

On today's episode of Catalysts, anchor Madison Mills and her guest host, RBC Capital Markets equity derivatives strategist Amy Wu Silverman, keep investors up to date with their live market coverage ...